Global /China /Healthcare /Drug Manufacturers - General /600557

Jiangsu Kanion Pharmaceutical Co.,Ltd.

600557

• SSE: 600557 • Delayed

13.48CNY -3.4%

1.99 USD

As of 14 June 2026, Jiangsu Kanion Pharmaceutical Co.,Ltd. has a market cap of $1.17B USD, ranking #9853 globally and #2708 in China. It ranks #860 in the Healthcare sector, and #322 in the Drug Manufacturers - General industry.

Global Rank

9853

Country Rank

2708

Sector Rank

860

Industry Rank

322

Key Stats

Market Cap

$1.17BUSD

7.9B CNY

Enterprise Value

$878.44MUSD

5.94B CNY

Revenue (TTM)

$485.97MUSD

3.29B CNY

EBITDA (TTM)

$83.67MUSD

566.21M CNY

Net Income (TTM)

$44.85MUSD

303.93M CNY

EBITDA Margin

17%

Profit Margin

9.2%

PE Ratio

25.8

Forward PE

22.5

PS Ratio

2.4

PB Ratio

1.6

EV/EBITDA

10.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yongchun Yang open_in_new

Employees

6,132

Founded

1975

Website

kanion.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.4%	-6.8%	0.2%	-7.9%	-7%	-4.5%	5%	-54%	31%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600557 江苏康缘药业股份有限公司 Class A ISIN: CNE000001CL7 Shares Out.: Shares Outstanding: 566.159M¹ Shares Float: 312.623M² TV: TradingView: SSE: 600557 SA: Stock Analysis: SHA: 600557 YF: Yahoo Finance: 600557.SS GF: Google Finance: SHA: 600557 BA: Barron's: 600557 MS: Morningstar: XSHG: 600557	13.48 CNY	TV: TradingView: SSE: 600557 SA: Stock Analysis: SHA: 600557 YF: Yahoo Finance: 600557.SS GF: Google Finance: SHA: 600557 BA: Barron's: 600557 MS: Morningstar: XSHG: 600557

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jiangsu Kanion Pharmaceutical Co.,Ltd.

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 5K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 65K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 47K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 31K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 27K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 25K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 23K%	20.5	Switzerland

chevron_leftBack